Interactive worksheet
Bleeding Risk vs Ischemic Benefit DAPT Balance Tool
Explanation and Clinical Context Dual antiplatelet therapy combining aspirin and a P2Y12 receptor inhibitor is a cornerstone of treatment after acute coronary syndromes. The 2025 American Heart Association acute coronary syndromes guideline emphasizes that the intensity and duration of antiplatelet therapy should be individualized by balancing ischemic benefit against bleeding risk within a structured clinical decisi